These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8290682)
1. Nortriptyline in the hospitalized elderly: tolerance and side effect reduction. Rosen J; Sweet R; Pollock BG; Mulsant BH Psychopharmacol Bull; 1993; 29(2):327-31. PubMed ID: 8290682 [TBL] [Abstract][Full Text] [Related]
2. Treatment of nortriptyline's side effects in elderly patients: a double-blind study of bethanechol. Rosen J; Pollock BG; Altieri LP; Jonas EA Am J Psychiatry; 1993 Aug; 150(8):1249-51. PubMed ID: 8101048 [TBL] [Abstract][Full Text] [Related]
3. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial. Kok RM; Nolen WA; Heeren TJ Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523 [TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients. Georgotas A; McCue RE; Friedman E; Cooper TB J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263 [TBL] [Abstract][Full Text] [Related]
5. Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. Geller B; Cooper TB; Graham DL; Marsteller FA; Bryant DM Psychopharmacol Bull; 1990; 26(1):85-90. PubMed ID: 2196631 [TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled assessment of nortriptyline's side-effects during 3-year maintenance treatment in elderly patients with recurrent major depression. Marraccini RL; Reynolds CF; Houck PR; Miller MD; Frank E; Perel JM; Cornes C; Mazumdar S; Kupfer DJ Int J Geriatr Psychiatry; 1999 Dec; 14(12):1014-8. PubMed ID: 10607968 [TBL] [Abstract][Full Text] [Related]
8. Maintenance nortriptyline effects on electroencephalographic sleep in elderly patients with recurrent major depression: double-blind, placebo- and plasma-level-controlled evaluation. Reynolds CF; Buysse DJ; Brunner DP; Begley AE; Dew MA; Hoch CC; Hall M; Houck PR; Mazumdar S; Perel JM; Kupfer DJ Biol Psychiatry; 1997 Oct; 42(7):560-7. PubMed ID: 9376452 [TBL] [Abstract][Full Text] [Related]
9. Pretreatment systolic orthostatic blood pressure and treatment response in geriatric depression: a revisit. Diehl DJ; Houck PR; Paradis C; Miller M; Reynolds CF J Clin Psychopharmacol; 1993 Jun; 13(3):189-93. PubMed ID: 8354735 [TBL] [Abstract][Full Text] [Related]
10. Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients. Laghrissi-Thode F; Pollock BG; Miller MC; Mulsant BH; Altieri L; Finkel MS Psychopharmacol Bull; 1995; 31(4):659-63. PubMed ID: 8851637 [TBL] [Abstract][Full Text] [Related]
11. Outcome of late-life depression after 3 years of sequential treatment. Kok RM; Nolen WA; Heeren TJ Acta Psychiatr Scand; 2009 Apr; 119(4):274-81. PubMed ID: 19053970 [TBL] [Abstract][Full Text] [Related]
12. Antidepressant treatment of tinnitus patients: report of a randomized clinical trial and clinical prediction of benefit. Dobie RA; Sakai CS; Sullivan MD; Katon WJ; Russo J Am J Otol; 1993 Jan; 14(1):18-23. PubMed ID: 8424470 [TBL] [Abstract][Full Text] [Related]
13. High initial nortriptyline doses in the treatment of depression. Warner MD; Griffin M; Peabody CA J Clin Psychiatry; 1993 Feb; 54(2):67-9. PubMed ID: 8444823 [TBL] [Abstract][Full Text] [Related]
14. Effects of nortriptyline on memory self-assessment and performance in recovered elderly depressives. Meyers BS; Mattis S; Gabriele M; Kakuma T Psychopharmacol Bull; 1991; 27(3):295-9. PubMed ID: 1775602 [TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of serum nortriptyline and 10-hydroxy-nortriptyline measurements in the depressed elderly: a multicenter pharmacokinetic and pharmacodynamic study. Kin NM; Klitgaard N; Nair NP; Amin M; Kragh-Sorensen P; Schwariz G; Ahmed SK; Holm P; Katona C; Stage K Neuropsychopharmacology; 1996 Jul; 15(1):1-6. PubMed ID: 8797186 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic treatment of major depression for elderly patients in residential care settings. Katz IR; Simpson GM; Curlik SM; Parmelee PA; Muhly C J Clin Psychiatry; 1990 Jul; 51 Suppl():41-7; discussion 48. PubMed ID: 2195013 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder. Geller B; Cooper TB; Graham DL; Fetner HH; Marsteller FA; Wells JM J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):34-44. PubMed ID: 1537779 [TBL] [Abstract][Full Text] [Related]
18. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT. Flint AJ; Rifat SL Int J Geriatr Psychiatry; 1998 Jan; 13(1):23-8. PubMed ID: 9489577 [TBL] [Abstract][Full Text] [Related]
19. Double-blind, placebo-controlled study of nortriptyline in depressed children using a "fixed plasma level" design. Geller B; Cooper TB; McCombs HG; Graham D; Wells J Psychopharmacol Bull; 1989; 25(1):101-8. PubMed ID: 2672066 [No Abstract] [Full Text] [Related]
20. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study. Navarro V; Gastó C; Torres X; Masana G; Penadés R; Guarch J; Vázquez M; Serra M; Pujol N; Pintor L; Catalán R Am J Geriatr Psychiatry; 2008 Jun; 16(6):498-505. PubMed ID: 18515694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]